November 18, 2026
Health news, explained with evidence
LIVE

Feasibility Study Explores Antiviral Treatment for Long COVID

🏥 Public Health 2 min read 👁 3

A new feasibility trial has successfully tested the delivery of a five-day intravenous antiviral treatment for individuals suffering from long COVID. Researchers are now calling for larger clinical trials to determine the therapy's overall efficacy.

Feasibility Study Explores Antiviral Treatment for Long COVID🏥Public Health

Photo: Medical Xpress

Key points

  • The ERASE feasibility study successfully delivered a five-day intravenous antiviral treatment to 73 long COVID patients.
  • Participants reported improvements in fatigue, quality of life, and physical function, though the study was not designed to confirm treatment efficacy.
  • Researchers are now calling for a larger randomized controlled trial to definitively test if the antiviral medication works for long COVID.

A recent feasibility study, known as the ERASE trial, has demonstrated that administering a five-day intravenous antiviral treatment to patients with long COVID is both safe and logistically manageable. Published in the journal Oxford Open Immunology, the study involved 73 participants who received the treatment under the supervision of clinical teams from multiple NHS trusts and academic institutions.

While the primary goal of this research was to determine if the treatment protocol could be effectively delivered and monitored, participants reported promising improvements in their daily lives. Observations included reduced fatigue, better overall quality of life, and increased functional capacity as measured by timed walking tests.

It is important to note that this study was not designed to prove the effectiveness of the drug or confirm a causal link between the treatment and the reported symptom improvements. Because the trial lacked a control group for efficacy, researchers emphasize that these findings serve only as a foundation for future, large-scale randomized controlled trials. Patients experiencing symptoms of long COVID are encouraged to consult with their healthcare providers regarding current management strategies and to stay informed about ongoing clinical research.

What to know: The ERASE study confirms that intravenous antiviral treatment is feasible for long COVID patients, but further rigorous testing is required to determine if the drug is an effective medical intervention.

Source Medical Xpress — medicalxpress.com/news/2026-11-explores-potential-antiviral-treatment-a… ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.